State Board Of Administration Of Florida Retirement System Neurocrine Biosciences Inc Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

A detailed history of State Board Of Administration Of Florida Retirement System transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 97,533 shares of NBIX stock, worth $13.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

97,533

Previous 103,333 5.61%

Holding current value

$13.2 Million

Previous $14.2 Million 21.07%

% of portfolio

0.02%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$114.58 - $153.15 $664,564 - $888,270	-5,800 Reduced 5.61%	97,533 $11.2 Million
Q2 2024 Aug 08, 2024	SELL	$130.86 - $143.19 $799,947 - $875,320	-6,113 Reduced 5.59%	103,333 $14.2 Million
Q1 2024 May 08, 2024	BUY	$130.4 - $143.74 $280,751 - $309,472	2,153 Added 2.01%	109,446 $15.1 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $10,182 - $12,744	96 Added 0.09%	107,293 $14.1 Million
Q3 2023 Nov 08, 2023	BUY	$94.02 - $117.1 $14,103 - $17,565	150 Added 0.14%	107,197 $12.1 Million
Q2 2023 Aug 11, 2023	SELL	$89.53 - $104.87 $214,782 - $251,583	-2,399 Reduced 2.19%	107,047 $10.1 Million
Q4 2022 Feb 07, 2023	SELL	$106.72 - $127.06 $179,289 - $213,460	-1,680 Reduced 1.51%	109,446 $13.1 Million
Q3 2022 Nov 08, 2022	SELL	$92.03 - $107.81 $223,632 - $261,978	-2,430 Reduced 2.14%	111,126 $11.8 Million
Q2 2022 Aug 05, 2022	SELL	$75.79 - $100.07 $688,552 - $909,135	-9,085 Reduced 7.41%	113,556 $11.1 Million
Q1 2022 May 06, 2022	SELL	$72.45 - $94.81 $7,969 - $10,429	-110 Reduced 0.09%	122,641 $11.5 Million
Q4 2021 Feb 08, 2022	SELL	$79.65 - $106.22 $46,356 - $61,820	-582 Reduced 0.47%	122,751 $10.5 Million
Q3 2021 Nov 08, 2021	SELL	$86.18 - $99.03 $279,050 - $320,659	-3,238 Reduced 2.56%	123,333 $11.8 Million
Q2 2021 Aug 10, 2021	SELL	$89.43 - $102.27 $1.63 Million - $1.86 Million	-18,229 Reduced 12.59%	126,571 $12.3 Million
Q1 2021 May 10, 2021	SELL	$87.57 - $119.4 $327,511 - $446,556	-3,740 Reduced 2.52%	144,800 $14.1 Million
Q4 2020 Feb 08, 2021	BUY	$86.91 - $108.33 $982,083 - $1.22 Million	11,300 Added 8.23%	148,540 $14.2 Million
Q3 2020 Nov 09, 2020	BUY	$96.16 - $135.15 $150,009 - $210,834	1,560 Added 1.15%	137,240 $13.2 Million
Q2 2020 Aug 07, 2020	BUY	$85.09 - $130.36 $1.17 Million - $1.79 Million	13,751 Added 11.28%	135,680 $16.6 Million
Q1 2020 May 05, 2020	BUY	$75.11 - $113.76 $45,516 - $68,938	606 Added 0.5%	121,929 $10.6 Million
Q4 2019 Feb 03, 2020	BUY	$86.8 - $118.57 $147,126 - $200,976	1,695 Added 1.42%	121,323 $13 Million
Q3 2019 Nov 07, 2019	SELL	$83.82 - $101.5 $15,003 - $18,168	-179 Reduced 0.15%	119,628 $10.8 Million
Q2 2019 Aug 05, 2019	BUY	$72.24 - $91.27 $294,233 - $371,742	4,073 Added 3.52%	119,807 $10.1 Million
Q1 2019 May 03, 2019	SELL	$69.31 - $91.53 $117,133 - $154,685	-1,690 Reduced 1.44%	115,734 $10.2 Million
Q4 2018 Feb 01, 2019	BUY	$68.32 - $124.36 $58,755 - $106,949	860 Added 0.74%	117,424 $8.39 Million
Q3 2018 Oct 31, 2018	SELL	$98.88 - $125.85 $405,605 - $516,236	-4,102 Reduced 3.4%	116,564 $14.3 Million
Q2 2018 Aug 06, 2018	BUY	$75.3 - $105.99 $132,528 - $186,542	1,760 Added 1.48%	120,666 $11.9 Million
Q1 2018 May 04, 2018	BUY	$75.88 - $92.43 $216,182 - $263,333	2,849 Added 2.45%	118,906 $9.86 Million
Q4 2017 Feb 01, 2018	SELL	$58.53 - $77.59 $255,717 - $338,990	-4,369 Reduced 3.63%	116,057 $9.01 Million
Q3 2017 Oct 31, 2017	BUY	$47.97 - $61.28 $5.78 Million - $7.38 Million	120,426	120,426 $7.38 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account

State Board Of Administration Of Florida Retirement System Neurocrine Biosciences Inc Transaction History